|
1
|
Ben Sahra I, Le Marchand-Brustel Y, Tanti
JF and Bost F: Metformin in cancer therapy: A new perspective for
an old anti-diabetic drug. Mol Cancer Ther. 9:1092–1099. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Evans JM, Donnelly LA, Emslie-Smith AM,
Alessi DR and Morris AD: Metformin and reduced risk of cancer in
diabetic patients. BMJ. 330:1304–1305. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gonzalez-Angulo AM and Meric-Bernstam F:
Metformin: A therapeutic opportunity in breast cancer. Clin Cancer
Res. 16:1695–1700. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gallagher EJ and LeRoith D: Diabetes,
cancer, and metformin: Connections of metabolism and cell
proliferation. Ann NY Acad Sci. 1243:54–68. 2011. View Article : Google Scholar
|
|
5
|
Soranna D, Scotti L, Zambon A, Bosetti C,
Grassi G, Catapano A, La Vecchia C, Mancia G and Corrao G: Cancer
risk associated with use of metformin and sulfonylurea in type 2
diabetes: A meta-analysis. Oncologist. 17:813–822. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Col NF, Ochs L, Springmann V, Aragaki AK
and Chlebowski RT: Metformin and breast cancer risk: A
meta-analysis and critical literature review. Breast Cancer Res
Treat. 135:639–646. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhuang Y and Miskimins WK: Cell cycle
arrest in metformin treated breast cancer cells involves activation
of AMPK, down-regulation of cyclin D1, and requires p27Kip1 or
p21Cip. J Mol Signal. 3:18–29. 2008. View Article : Google Scholar
|
|
8
|
Phoenix KN, Vumbaca F and Claffey KP:
Therapeutic metformin/AMPK activation promotes the angiogenic
phenotype in the ERalpha negative MDA-MB-435 breast cancer model.
Breast Cancer Res Treat. 113:101–111. 2009. View Article : Google Scholar :
|
|
9
|
Alimova IN, Liu B, Fan Z, Edgerton SM,
Dillon T, Lind SE and Thor AD: Metformin inhibits breast cancer
cell growth, colony formation and induces cell cycle arrest in
vitro. Cell Cycle. 8:909–915. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Feng YH, Velazquez-Torres G, Gully C, Chen
J, Lee MH and Yeung SC: The impact of type 2 diabetes and
antidiabetic drugs on cancer cell growth. J Cell Mol Med.
15:825–836. 2011. View Article : Google Scholar
|
|
11
|
Jalving M, Gietema JA, Lefrandt JD, de
Jong S, Reyners AK, Gans RO and de Vries EG: Metformin: Taking away
the candy for cancer. Eur J Cancer. 46:2369–2380. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Brown KA, Samarajeewa NU and Simpson ER:
Endocrine-related cancers and the role of AMPK. Mol Cell
Endocrinol. 366:170–179. 2013. View Article : Google Scholar
|
|
13
|
Li J, Kim SG and Blenis J: Rapamycin: One
drug, many effects. Cell Metab. 19:373–379. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Vazquez-Martin A, Oliveras-Ferraros C and
Menendez JA: The antidiabetic drug metformin suppresses HER2
(erbB-2) oncoprotein overexpression via inhibition of the mTOR
effector p70S6K1 in human breast carcinoma cells. Cell Cycle.
8:88–96. 2009. View Article : Google Scholar
|
|
15
|
Chetrite GS, Cortes-Prieto J, Philippe JC,
Wright F and Pasqualini JR: Comparison of estrogen concentrations,
estrone sulfatase and aromatase activities in normal, and in
cancerous, human breast tissues. J Steroid Biochem Mol Biol.
72:23–27. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Agarwal VR, Bulun SE, Leitch M, Rohrich R
and Simpson ER: Use of alternative promoters to express the
aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of
cancer-free and breast cancer patients. J Clin Endocrinol Metab.
81:3843–3849. 1996.PubMed/NCBI
|
|
17
|
Barnadas A, Estévez LG, Lluch-Hernández A,
Rodriguez-Lescure A, Rodriguez-Sanchez C and Sanchez-Rovira P: An
overview of letrozole in postmenopausal women with
hormone-responsive breast cancer. Adv Ther. 28:1045–1058. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cook KL, Shajahan AN and Clarke R:
Autophagy and endocrine resistance in breast cancer. Expert Rev
Anticancer Ther. 11:1283–1294. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Brown KA, Hunger NI, Docanto M and Simpson
ER: Metformin inhibits aromatase expression in human breast adipose
stromal cells via stimulation of AMP-activated protein kinase.
Breast Cancer Res Treat. 123:591–596. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Samarajeewa NU, Ham S, Yang F, Simpson ER
and Brown KA: Promoter-specific effects of metformin on aromatase
transcript expression. Steroids. 76:768–771. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Anastasius N, Boston S, Lacey M, Storing N
and Whitehead SA: Evidence that low-dose, long-term genistein
treatment inhibits oestradiol-stimulated growth in MCF-7 cells by
down-regulation of the PI3-kinase/Akt signalling pathway. J Steroid
Biochem Mol Biol. 116:50–55. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rice S, Amon A and Whitehead SA: Ethanolic
extracts of black cohosh (Actaea racemosa) inhibit growth and
oestradiol synthesis from oestrone sulphate in breast cancer cells.
Maturitas. 56:359–367. 2007. View Article : Google Scholar
|
|
23
|
Gilling-Smith C, Willis DS, Beard RW and
Franks S: Hypersecretion of androstenedione by isolated thecal
cells from polycystic ovaries. J Clin Endocrinol Metab.
79:1158–1165. 1994.PubMed/NCBI
|
|
24
|
Willis D, Mason H, Gilling-Smith C and
Franks S: Modulation by insulin of follicle-stimulating hormone and
luteinizing hormone actions in human granulosa cells of normal and
polycystic ovaries. J Clin Endocrinol Metab. 81:302–309.
1996.PubMed/NCBI
|
|
25
|
Rice S, Pellatt L, Ramanathan K, Whitehead
SA and Mason HD: Metformin inhibits aromatase via an extracellular
signal-regulated kinase-mediated pathway. Endocrinology.
150:4794–4801. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rice S, Elia A, Jawad Z, Pellatt L and
Mason HD: Metformin inhibits follicle-stimulating hormone (FSH)
action in human granulosa cells: Relevance to polycystic ovary
syndrome. J Clin Endocrinol Metab. 98:E1491–E1500. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Utsumi T, Yoshimura N, Takeuchi S, Maruta
M, Maeda K and Harada N: Elevated steroid sulfatase expression in
breast cancers. J Steroid Biochem Mol Biol. 73:141–145. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pfaffl MW: A new mathematical model for
relative quantification in real-time RT-PCR. Nucleic Acids Res.
29:e452001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Robert F, Fendri S, Hary L, Lacroix C,
Andréjak M and Lalau JD: Kinetics of plasma and erythrocyte
metformin after acute administration in healthy subjects. Diabetes
Metab. 29:279–283. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Christensen MM, Brasch-Andersen C, Green
H, Nielsen F, Damkier P, Beck-Nielsen H and Brosen K: The
pharmacogenetics of metformin and its impact on plasma metformin
steady-state levels and glycosylated hemoglobin A1c. Pharmacogenet
Genomics. 21:837–850. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jung JW, Park SB, Lee SJ, Seo MS, Trosko
JE and Kang KS: Metformin represses self-renewal of the human
breast carcinoma stem cells via inhibition of estrogen
receptor-mediated OCT4 expression. PLoS One. 6:e280682011.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Berstein LM, Yue W, Wang JP and Santen RJ:
Isolated and combined action of tamoxifen and metformin in
wild-type, tamoxifen-resistant, and estrogen-deprived MCF-7 cells.
Breast Cancer Res Treat. 128:109–117. 2011. View Article : Google Scholar
|
|
33
|
Ali S and Coombes RC: Endocrine-responsive
breast cancer and strategies for combating resistance. Nat Rev
Cancer. 2:101–112. 2002. View
Article : Google Scholar
|
|
34
|
Seto B: Rapamycin and mTOR: A
serendipitous discovery and implications for breast cancer. Clin
Transl Med. 1:292012. View Article : Google Scholar
|
|
35
|
Beretta L, Gingras AC, Svitkin YV, Hall MN
and Sonenberg N: Rapamycin blocks the phosphorylation of 4E-BP1 and
inhibits cap-dependent initiation of translation. EMBO J.
15:658–664. 1996.PubMed/NCBI
|
|
36
|
Dowling RJ, Zakikhani M, Fantus IG, Pollak
M and Sonenberg N: Metformin inhibits mammalian target of
rapamycin-dependent translation initiation in breast cancer cells.
Cancer Res. 67:10804–10812. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zakikhani M, Blouin MJ, Piura E and Pollak
MN: Metformin and rapamycin have distinct effects on the AKT
pathway and proliferation in breast cancer cells. Breast Cancer Res
Treat. 123:271–279. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lalau JD, Lemaire-Hurtel AS and Lacroix C:
Establishment of a database of metformin plasma concentrations and
erythrocyte levels in normal and emergency situations. Clin Drug
Investig. 31:435–438. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Campagnoli C and Berrino F: Venturelli E,
Abbà C, Biglia N, Brucato T, Cogliati P, Danese S, Donadio M, Zito
G, Pasanisi P: Metformin dereases circulating androgen and
oestrogen levels in nondiabetic women with breast cancer. Breast
Cancer. 13:433–438. 2013. View Article : Google Scholar
|
|
40
|
Mansfield R, Galea R, Brincat M, Hole D
and Mason H: Metformin has direct effects on human ovarian
steroidogenesis. Fertil Steril. 79:956–962. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Foster PA, Chander SK, Newman SP, et al: A
new therapeutic strategy against hormone-dependent breast cancer:
The preclinical development of a dual aromatase and sulfatase
inhibitor. Clin Cancer Res. 14:6469–6477. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Aka JA, Mazumdar M and Lin SX: Reductive
17beta-hydroxysteroid dehydrogenases in the sulfatase pathway:
Critical in the cell proliferation of breast cancer. Mol Cell
Endocrinol. 301:183–190. 2009. View Article : Google Scholar
|
|
43
|
Osborne CK and Schiff R: Mechansims of
endocrine resistance in breast cancer. Annu Rev Med. 62:233–247.
2011. View Article : Google Scholar
|
|
44
|
Zhu Z, Jiang W, Thompson MD, McGinley JN
and Thompson HJ: Metformin as an energy restriction mimetic agent
for breast cancer prevention. J Carcinog. 10:172011. View Article : Google Scholar : PubMed/NCBI
|
